Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of ADC-189 and Itraconazole in Healthy Adults
NCT06589635Phase 1Completed
- Sponsor
- Jiaxing AnDiCon Biotech
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of deunoxavir marboxil in influenza, sponsored by Jiaxing AnDiCon Biotech. Primary endpoints: Area Under the Curve from time zero to infinity, Maximum Plasma Concentration and 2 more. Started Jul 2024; status: completed.
02
Drugs
deunoxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06589635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06589635.